<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">jofin</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал инфектологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Infectology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-6732</issn><publisher><publisher-name>IPO “АIDSSPbR"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22625/2072-6732-2023-15-4-54-61</article-id><article-id custom-type="elpub" pub-id-type="custom">jofin-1567</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальное исследование</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Поражение печени при инфекционном мононуклеозе у детей</article-title><trans-title-group xml:lang="en"><trans-title>Liver damage in infectious mononucleosis in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Халиуллина</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khaliullina</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Халиуллина Светлана Викторовна – профессор кафедры детских инфекций;</p><p>профессор кафедры внутренних болезней, д.м.н., доцент; тел.: 8(843)267-80-06</p><p>Казань</p></bio><bio xml:lang="en"><p>Kazan</p></bio><email xlink:type="simple">svekhal@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Якупова</surname><given-names>Ф. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Yakupova</surname><given-names>F. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Якупова Фарида Мударисовна – доцент кафедры инфекционных болезней;</p><p>доцент кафедры внутренних болезней, к.м.н.; тел.: 8(843)267-80-71</p><p>Казань</p></bio><bio xml:lang="en"><p>Kazan</p></bio><email xlink:type="simple">faridaleto@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Насырова</surname><given-names>Э. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Nasyrova</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Насырова Эльмира Ильдаровна – ординатор кафедры детских инфекций;</p><p>врач-стажер; тел.: 8(843)267-80-06</p><p>Казань</p></bio><bio xml:lang="en"><p>Kazan</p></bio><email xlink:type="simple">luxan7@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михайлова</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhailova</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михайлова Кристина Васильевна – ординатор кафедры внутренних болезней; тел.: 8(843)236-78-92</p><p>Казань</p></bio><bio xml:lang="en"><p>Kazan</p></bio><email xlink:type="simple">1830061999@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Раимова</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Raimova</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Раимова Юлия Алексеевна – аспирант кафедры детских инфекций;</p><p>врач; тел.: 8(843)267-80-06</p><p>Казань</p></bio><bio xml:lang="en"><p>Kazan</p></bio><email xlink:type="simple">july_rai@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Назарова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nazarova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Назарова Ольга Александровна – доцент кафедры эпидемиологии и доказательной медицины, к.м.н.; тел.: +7-917-877-88-02</p><p>Казань</p></bio><bio xml:lang="en"><p>Kazan</p></bio><email xlink:type="simple">nazarovaoa76@mail.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анохин</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Anokhin</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анохин Владимир Алексеевич – заведующий кафедрой детских инфекций, д.м.н., профессор; тел.: 8(843)267-81-00</p><p>Казань</p></bio><bio xml:lang="en"><p>Kazan</p></bio><email xlink:type="simple">anokhin56@mail.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Казанский государственный медицинский университет;&#13;
Институт фундаментальной медицины и биологии Казанского (Приволжского) федерального университета</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University;&#13;
Institute of Fundamental Medicine and Biology of Kazan (Volga Region) Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Казанский государственный медицинский университет;&#13;
Республиканская клиническая инфекционная больница имени профессора А.Ф. Агафонова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University;&#13;
Republican Clinical Infectious Diseases Hospital named after Professor A.F. Agafonov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Институт фундаментальной медицины и биологии Казанского (Приволжского) федерального университета</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Fundamental Medicine and Biology of Kazan (Volga Region) Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Казанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>11</day><month>01</month><year>2024</year></pub-date><volume>15</volume><issue>4</issue><fpage>54</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Халиуллина С.В., Якупова Ф.М., Насырова Э.И., Михайлова К.В., Раимова Ю.А., Назарова О.А., Анохин В.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Халиуллина С.В., Якупова Ф.М., Насырова Э.И., Михайлова К.В., Раимова Ю.А., Назарова О.А., Анохин В.А.</copyright-holder><copyright-holder xml:lang="en">Khaliullina S.V., Yakupova F.M., Nasyrova E.I., Mikhailova K.V., Raimova Y.A., Nazarova O.A., Anokhin V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.niidi.ru/jofin/article/view/1567">https://journal.niidi.ru/jofin/article/view/1567</self-uri><abstract><p>Цель: оценить клинико-лабораторные особенности инфекционного мононуклеоза, протекающего с поражением печени у детей, госпитализированных в инфекционный стационар.Материалы и методы: с января 2018 г. по июнь 2021 г. проведено сравнительное ретроспективное исследование. Методом случайной выборки отобрано 200 медицинских карт стационарного больного. Критерии включения: возраст от 1 года до 17 лет, клиника инфекционного мононуклеоза, отсутствие тяжелой сопутствующей патологии. Все пациенты проходили стандартное лабораторное обследование, дополнительно определяли ДНК герпес-вирусов в крови методом полимеразной цепной реакции. В зависимости от наличия синдрома цитолиза (уровень АЛТ &gt; 31 Ед/л) все пациенты были распределены на 2 группы: дети с наличием печеночных проявлений ИМН – 80 пациентов (40%) и без них – 120 (60%). Статистический анализ полученных результатов проводили с использованием статистической программы Statistica 8 (USA).Результаты: вирус Эпштейна – Барр был причиной развития клиники инфекционного мононуклеоза в 59% (118/200) случаев моноинфекции и в 14,5% (29/200) в сочетании с другими герпес-вирусами. Все участники исследования переносили заболевание в среднетяжелой форме. Повышение уровня аланинаминотрансферазы выше 150 U/L регистрировали у 9,5% (19/200) обследованных, более 1000 U/L не было ни у кого, медиана составила 72,5 (МКР 48–138,5) U/L. Поражение печени чаще регистрировали у детей старше 3 лет, преобладали девочки (53,8%, р = 0,017). У пациентов с поражением печени регистрировали: умеренно выраженные лихорадку и лимфаденопатию (р &lt; 0,05), гепатоспленомегалию (р &lt; 0,001), лимфоцитарный лейкоцитоз (р &lt; 0,05), тромбоцитопению (р &lt; 0,001), чаще выявляли атипичные мононуклеары (р &lt; 0,001), реже повышение уровня СРБ (р = 0,008).Выводы. Наше исследование показало, что поражение печени при инфекционном мононуклеозе регистрируется у 40% госпитализированных детей. Очевидно, что дети со среднетяжелыми формами инфекционного мононуклеоза нуждаются в лабораторном и инструментальном контроле за состоянием гепатобилиарной системы и соответствующей коррекции терапии.</p></abstract><trans-abstract xml:lang="en"><p>The purpose of the study was to evaluate the clinical and laboratory features of infectious mononucleosis with liver damage in children hospitalized in an infectious diseases hospital.Materials and methods. A comparative retrospective study was conducted from January 2018 to June 2021. 200 Medical records of an inpatient were selected by random sampling. Inclusion criteria: age from 1 to 17 years, clinical presentation of infectious mononucleosis, absence of severe concomitant pathology. All patients underwent a standard laboratory examination, additionally determined the DNA of herpes viruses in the blood by PCR. Depending on the presence of cytolysis syndrome (ALT level &gt; 31 U/l), all patients were divided into 2 groups: children with hepatic manifestations of IMN – 80 patients (40%) and without them – 120 (60%). Statistical analysis of the obtained results was carried out using the statistical program Statistica 8 (USA).Results. Epstein – Barr virus was the cause of the development of IMN clinic in 59% (118/200) of cases of monoinfection and in 14.5% (29/200) in combination with other herpesviruses. All participants in the study had moderate disease. An increase in the level of alanine aminotransferase (ALT) above 150 U/L was recorded in 9.5% (19/200) of the examined, no one had more than 1000 U/L, the median was 72.5 (MKR 48–138.5) U/L. Liver damage was more often recorded in children older than 3 years, girls predominated (53.8%, p = 0.017). In patients with liver damage, the following were recorded: moderately severe fever and lymphadenopathy (p &lt; 0.05), hepatosplenomegaly (p &lt; 0.001), lymphocytic leukocytosis (p &lt; 0.05), thrombocytopenia (p &lt; 0.001), atypical mononuclear cells were detected more often (p &lt; 0.001), less often an increase in the level of CRP (p = 0.008).Conclusions. Our study showed that liver damage in IMN is registered in 40% of hospitalized children. Obviously, children with moderate forms of IMN need laboratory and instrumental monitoring of the state of the hepatobiliary system and appropriate correction of therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфекционный мононуклеоз</kwd><kwd>поражение печени</kwd><kwd>синдром цитолиза</kwd><kwd>герпес-вирусы</kwd><kwd>дети</kwd></kwd-group><kwd-group xml:lang="en"><kwd>infectious mononucleosis</kwd><kwd>liver damage</kwd><kwd>cytolysis syndrome</kwd><kwd>herpesviruses</kwd><kwd>children</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Méndez-Sánchez, Nahum. Hepatic manifestations of Epstein-Barr viral infection / Nahum Méndez-Sánchez, Cecilia Aguilar-Domínguez, Norberto C. Chávez-Tapia, Misael Uribe // Annals of Hepatology. – 2005. – Vol. 4, Iss. 3. – Pp. 205–209.</mixed-citation><mixed-citation xml:lang="en">Méndez-Sánchez, Nahum. Hepatic manifestations of Epstein-Barr viral infection / Nahum Méndez-Sánchez, Cecilia Aguilar-Domínguez, Norberto C. Chávez-Tapia, Misael Uribe // Annals of Hepatology. – 2005. – Vol. 4, Iss. 3. – Pp. 205–209.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Petrova, М. Epstein-Barr virus: Silent companion or causative agent of chronic liver disease? / M. Petrova, V. Kamburov // World Journal of Gastroenterology. – 2010. – Vol. 16, Iss. 33. – Pp. 4130–4134.</mixed-citation><mixed-citation xml:lang="en">Petrova, M. Epstein-Barr virus: Silent companion or causative agent of chronic liver disease? / M. Petrova, V. Kamburov // World Journal of Gastroenterology. – 2010. – Vol. 16, Iss. 33. – Pp. 4130–4134.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bunchorntavakul, Chalermrat. Epstein-Barr Virus and Cytomegalovirus Infections of the Liver / Chalermrat Bunchorntavakul, K. Rajender Reddy // Gastroenterology Clinics of North America. – 2020. – Vol. 49, Iss. 2. – Pp. 331–346.</mixed-citation><mixed-citation xml:lang="en">Bunchorntavakul, Chalermrat. Epstein-Barr Virus and Cytomegalovirus Infections of the Liver / Chalermrat Bunchorntavakul, K. Rajender Reddy // Gastroenterology Clinics of North America. – 2020. – Vol. 49, Iss. 2. – Pp. 331–346.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Вирусы группы герпеса и поражения печени / Г. Г. Тотолян [и др.] // Лечебное дело. – 2009. – № 2. – С. 4–11.</mixed-citation><mixed-citation xml:lang="en">Virusy gruppy gerpesa i porazhenija pecheni / G. G. Totoljan, G. I. Storozhakov, I. G. Fedorov [i dr.] // Lechebnoe delo. – 2009. – № 2. – S. 4–11.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Vento, Sandro. Is there a role for viruses in triggering autoimmune hepatitis? / Sandro Vento, Francesca Cainelli // Autoimmunity Reviews. – 2004. – Vol. 3, Iss. 1. – Pp. 61–69.</mixed-citation><mixed-citation xml:lang="en">Vento, Sandro. Is there a role for viruses in triggering autoimmune hepatitis? / Sandro Vento, Francesca Cainelli // Autoimmunity Reviews. – 2004. – Vol. 3, Iss. 1. – Pp. 61–69.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Case Report: A Case of Epstein-Barr Virus-Associated Acute Liver Failure Requiring Hematopoietic Cell Transplantation After Emergent Liver Transplantation [Электронный ресурс] / Koji Nakajima, Eitaro Hiejima1, Hiroshi Nihira [et al.] // Frontiers in Immunology. – 2022. – Vol. 13. – DOI: https://doi.org/10.3389/fimmu.2022.825806 (дата обращения: 29.08.2023).</mixed-citation><mixed-citation xml:lang="en">Case Report: A Case of Epstein-Barr Virus-Associated Acute Liver Failure Requiring Hematopoietic Cell Transplantation After Emergent Liver Transplantation [Jelektronnyj resurs] / Koji Nakajima, Eitaro Hiejima1, Hiroshi Nihira [et al.] // Frontiers in Immunology. – 2022. – Vol. 13. – DOI: https://doi.org/10.3389/fimmu.2022.825806 (data obrashhenija: 29.08.2023).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Epstein-Barr virus infection is associated with a higher Child-Pugh score and may predict poor prognoses for patients with liver cirrhosiss [Электронный ресурс] / Jianhua Hu, Xiaoli Zhang, Guodong Yu [et al.] // BMC Gastroenterology. – 2019. – Vol. 19, Iss. 94. – DOI: https://doi.org/10.1186/s12876-019-1021-1 (дата обращения: 29.08.2023).</mixed-citation><mixed-citation xml:lang="en">Epstein-Barr virus infection is associated with a higher Child-Pugh score and may predict poor prognoses for patients with liver cirrhosiss [Jelektronnyj resurs] / Jianhua Hu, Xiaoli Zhang, Guodong Yu [et al.] // BMC Gastroenterology. – 2019. – Vol. 19, Iss. 94. – DOI: https://doi.org/10.1186/s12876-019-1021-1 (data obrashhenija: 29.08.2023).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Da Cunha, Тeresa. Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis [Электронный ресурс] / Т. Da Cunha, Sheena Mago, Roopjeet K. Bath // Cureus. – 2022. – Vol. 14, Iss. 4. – DOI: 10.7759/cureus.24552 (дата обращения: 29.08.2023).</mixed-citation><mixed-citation xml:lang="en">Da Cunha, Teresa. Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis [Jelektronnyj resurs] / T. Da Cunha, Sheena Mago, Roopjeet K. Bath // Cureus. – 2022. – Vol. 14, Iss. 4. – DOI: 10.7759/cureus.24552 (data obrashhenija: 29.08.2023).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Moss, Р. The T cell immune response against SARSCoV-2 / P. Moss // Nature immunology. – 2022. – Vol. 23. – Рp. 186–193.</mixed-citation><mixed-citation xml:lang="en">Moss, R. The T cell immune response against SARSCoV-2 / P. Moss // Nature immunology. – 2022. – Vol. 23. – Rp. 186–193.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kudlay, D. Peculiarities of the T Cell Immune Response in COVID-19 [Электронный ресурс] / D. Kudlay, I. Kofiadi, M. Khaitov // Vaccines (Basel). – 2022. – Vol. 10, Iss. 2. – DOI: 10.3390/vaccines10020242 (дата обращения: 29.08.2023).</mixed-citation><mixed-citation xml:lang="en">Kudlay, D. Peculiarities of the T Cell Immune Response in COVID-19 [Jelektronnyj resurs] / D. Kudlay, I. Kofiadi, M. Khaitov // Vaccines (Basel). – 2022. – Vol. 10, Iss. 2. – DOI: 10.3390/vaccines10020242 (data obrashhenija: 29.08.2023).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hermens, J. Maret. Role of T cells in severe COVID-19 disease, protection and long term immunity / Julia Maret Hermens, Can Kesmir // Immunogenetics. – 2023. – Vol. 75, Iss. 3. – Рp. 295–307.</mixed-citation><mixed-citation xml:lang="en">Hermens, J. Maret. Role of T cells in severe COVID-19 disease, protection and long term immunity / Julia Maret Hermens, Can Kesmir // Immunogenetics. – 2023. – Vol. 75, Iss. 3. – Rp. 295–307.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Реактивация герпес-вирусов – одна из возможных причин развития post-COVID-19 / С.В. Халиуллина, [и др.] // Вопросы практической педиатрии. – 2023. – Т. 18, № 3. – С. 100–107.</mixed-citation><mixed-citation xml:lang="en">Reaktivacija gerpesvirusov – odna iz vozmozhnyh prichin razvitija post-COVID-19 / S. V. Haliullina, V. A. Anohin, Ju. A. Raimova [i dr.] // Voprosy prakticheskoj pediatrii. – 2023. – T. 18, № 3. – S. 100–107.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rutkowska, M. Epstein Barr Virus Hepatitis – A Mild Clinical Symptom or a Threat? [Электронный ресурс] / M. Rutkowska, M. Pokorska-Śpiewak // Vaccines. – 2023. – Vol. 11, Iss. 6. – DOI: https://doi.org/10.3390/vaccines11061119 (дата обращения: 29.08.2023).</mixed-citation><mixed-citation xml:lang="en">Rutkowska, M. Epstein Barr Virus Hepatitis – A Mild Clinical Symptom or a Threat? [Jelektronnyj resurs] / M. Rutkowska, M. Pokorska-Śpiewak // Vaccines. – 2023. – Vol. 11, Iss. 6. – DOI: https://doi.org/10.3390/vaccines11061119 (data obrashhenija: 29.08.2023).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bunchorntavakul, Ch. Epstein-Barr Virus and Cytomegalovirus Infections of the Liver / Ch. Bunchorntavakul, K. Rajender Reddy // Gastroenterology Clinics of North America. – 2020. – Vol. 49, Iss. 2. – Рp. 331–346.</mixed-citation><mixed-citation xml:lang="en">Bunchorntavakul, Ch. Epstein-Barr Virus and Cytomegalovirus Infections of the Liver / Ch. Bunchorntavakul, K. Rajender Reddy // Gastroenterology Clinics of North America. – 2020. – Vol. 49, Iss. 2. – Rp. 331–346.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
